Campistol J., Campos J., Casas C., Herranz JLTopiramate in the prophylactic treatment of migraine in children. J Child Neurol.2005;20:251-253.
2.
Gupta VKASD closure for migraine: is there a scientific basis?Eur Heart J.2005;26:1446.
3.
Gupta VKBotulinum toxin for treatment of migraine: randomized controlled trials versus basic sciences [eLetter]. J Neurol Neurosurg Psychiatry. 2004. Available at: http://jnnp.bmjjournals.com/cgi/eletters/75/7/951#212.
4.
Gupta VKMagnesium therapy for migraine: do we need more trials or more reflection?Headache. 2004;44:445-446.
5.
Gupta VKNon-lateralizing brain PET changes in migraine: phenomenology versus pharmacology?Brain. 2004;127:E12.
6.
Silberstein SD , Young WBMigraine aura and prodrome. Semin Neurol.1995;15:175-182.
7.
Yu W., Horowitz SHTreatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil . Neurology. 2003;56: 213-220.
8.
Gupta VKManagement of migraine aura: basic theoretical and clinical reconsiderations . Headache. In press.
9.
Bonuso S., Marano E., Stasio ED, Sorge F., Barbieri F., Ullucci E.Source of pain and primitive dysfunction in migraine: an identical site?J Neurol Neurosurg Psychiatry. 1989;52:1351-1354.
10.
Gupta VKMigraine, epilepsy, and brain neuronal hyperexcitation. Headache . 2005;45:89.
11.
De Simone R, Marano E., Di Stasio E, Bonuso S., Fiorillo C., Bonavita V.Acetazolamide efficacy and tolerability in migraine with aura: a pilot study. Headache. 2005;45:385-386.
12.
Spacey SD, Hildebrand ME, Materek LA, Bird TD, Snutch TPFunctional implications of a novel EA2 mutation in the P/Qtype calcium channel . Ann Neurol.2004;56:213-220.
13.
Murphy VA, Johanson CEAcidosis, acetazolamide, and amiloride: effects on 22Na transfer across the blood-brain and blood-CSF barriers. J Neurochem. 1989;52:1058-1063.
14.
Pascual J., Caminero AB, Mateos V., et al. Preventing disturbing migraine aura with lamotrigine: an open study. Headache. 2004; 44:1024-1028.
